MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    NS-PARK/FCRIN network, the French Clinical Research Network for Parkinson’s disease and Movement Disorders

    E. Dellapina, V. Chaigneau, F. Durif, J.-C. Corvol, O. Rascol, F. NS-PARK/FCRIN network (Toulouse, France)

    Objective: The objective of NS-PARK/FCRIN network (http://www.parkinson.network/) is to facilitate and stimulate clinical academic and industrial research in France in the field of Parkinson's disease…
  • 2017 International Congress

    Prevalence of Babinski-2 sign in Hemifacial Spasm Patients

    O. Dogu, H. Kalegasi (Mersin, Turkey)

    Objective: To assess the frequency of Babinski-2 sign among patients with hemifacial spasm (HFS). Background: The Babinski-2 sign (“the other” Babinski sign, “brow-lift sign”), is…
  • 2017 International Congress

    Effect of object size and obstacle avoidance on of Reach-to-Grasp Actions in Individuals with Parkinson’s disease

    S. Khacharoen, J. Tretriluxana, P. Srivanitchapoom, A. Pisarnpong, T. Chandharohit (Nakhon Pathom, Thailand)

    Objective: To investigate the effect of object size and obstacle on reach-to-grasp (RTG) actions in individuals Parkinson's disease (PD). Background: Previous studies reported impairments of…
  • 2017 International Congress

    Death in patients with Parkinson’s disease – an observational study

    R. Mappilakkandy, A. Pieris, D. Miodrag, A. Chunduri (Northampton, United Kingdom)

    Objective: We aimed to analyse the major cause and contributory reasons for death in patients with Parkinson’s disease (PD) who were known to our PD…
  • 2017 International Congress

    Inpatient care for stiff person syndrome in the United States: A nationwide readmission study

    J. Crispo, D. Thibault, Y. Fortin, A. Willis (Sudbury, ON, Canada)

    Objective: To describe national inpatient care for stiff person syndrome (SPS) in the United States and characterize all-cause 30-day readmission. Background: SPS is a rare…
  • 2017 International Congress

    Gait and Balance Impairment After Methanol Intoxication

    K. Peterová, H. Brožová, J. Klempíř, I. Lišková, S. Zakharov, O. Bezdíček, M. Vaněčková, Z. Seidl, E. Růžička (Prague, Czech Republic)

    Objective: We analyzed gait and postural instability in patients after methanol intoxication, with the aim to verify prevailing parkinsonian gait pattern. Background: Methanol is a…
  • 2017 International Congress

    A combined cognitive and motor exercise program for people with Parkinson’s disease and Freezing of gait; a pilot study.

    L. King, K. Smulders, M. Mancini, J. Lapidus, P. Carlson-Kuhta, B. Fling, J. Nutt, F. Horak (Portland, OR, USA)

    Objective: The purpose of this pilot study was to explore whether this combined cognitive and motor exercise program would 1) improve freezing of gait (FOG)…
  • 2017 International Congress

    Treatment of Functional Neurological Disorders: Towards Expert Consensus Led Guidelines for the American Neuropsychiatric Association Committee for Research

    O. Ghaffar, M. Modirrousta, C. LaFrance, N. Williams, R. Shura, S. Ducharme, V. Voon (Whitby, ON, Canada)

    Objective: To develop evidence-based, expert consensus recommendations for the treatment of functional neurological disorders (FND) on behalf of the ANPA Committee for Research. Background: FND…
  • 2017 International Congress

    Optimization and evaluation of whole body MRI sequences for patients with deep brain stimulators

    C. Drews, S. Wolff, L. Lunden, O. Jansen (Kiel, Germany)

    Objective: The aim of the study was to optimize MRI sequences in order to make possible a safe MRI examination for DBS patients. The optimized…
  • 2017 International Congress

    Epidemiological profile and challenges of a reference public center for the treatment of neurological conditions using botulinum toxin type A: experience of a North-eastern center in Brazil.

    R. Prado, W. Cunha, P. Macêdo, A. Santiago, R. Sá, J. Santos, M. Machado (Aracaju, Brazil)

    Objective: To identify the epidemiological profile of patients treated with botulinum toxin type A (BTA) in a tertiary clinic in Brazil. Background: BTA is used to…
  • « Previous Page
  • 1
  • …
  • 1499
  • 1500
  • 1501
  • 1502
  • 1503
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley